GRAFTcath Frequently Asked Questions (FAQ)
Where is GRAFTcath's headquarters?
GRAFTcath's headquarters is located at Marlborough.
What is GRAFTcath's latest funding round?
GRAFTcath's latest funding round is Corporate Minority.
Who are the investors of GRAFTcath?
Investors of GRAFTcath include Boston Scientific Ventures and Cutlass Capital.
Who are GRAFTcath's competitors?
Competitors of GRAFTcath include MedShape, Respicardia, Access Scientific, Vascular Pathways, arstasis and 7 more.
Compare GRAFTcath to Competitors
ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.
Primaeva Medical is an early stage medical device company developing a skin tightening and rejuvenation dermatological device
Endothelix is a company with a focus on non-invasive vascular function measurement within the cardiovascular device industry. Its main product, VENDYS, offers a non-invasive, FDA-approved test to assess endothelial function in a simple and cost-effective manner. The company markets its products to healthcare providers and patients, aiming to improve cardiovascular health diagnostics. It was founded in 2003 and is based in Houston, Texas.
Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors. It was founded in 2000 and is based in Westminster, Colorado.
InterRad Medical specializes in innovative catheter securement solutions within the healthcare sector. The company's flagship product, the SecurAcath, is a device that secures catheters subcutaneously without the need for adhesives or sutures, designed to reduce complications and improve patient care. InterRad Medical's products are primarily utilized in the healthcare industry, with a focus on improving outcomes for patients requiring catheterization. It was founded in 2000 and is based in Plymouth, Minnesota.
Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.